254
Views
0
CrossRef citations to date
0
Altmetric
Articles

Multilevel Influences on Patient-Oncologist Communication about Genomic Test Results: Oncologist Perspectives

, , , , , , & show all

References

  • Braddock, C. H., III, Edwards, K. A., Hasenberg, N. M., Laidley, T. L., & Levinson, W. (1999). Informed decision making in outpatient practice: Time to get back to basics. JAMA, 282(24), 2313–2320.
  • Brandes, K., Linn, A. J., Smit, E. G., & Van Weert, J. C. (2015). Patients’ reports of barriers to expressing concerns during cancer consultations. Patient Education and Counseling, 98(3), 317–322. doi:10.1016/j.pec.2014.11.021
  • Brewer, N. T., Richman, A. R., DeFrank, J. T., Reyna, V. F., & Carey, L. A. (2012). Improving communication of breast cancer recurrence risk. Breast Cancer Research and Treatment, 133(2), 553–561. doi:10.1007/s10549-011-1791-9
  • Brewer, N. T., Tzeng, J. P., Lillie, S. E., Edwards, A. S., Peppercorn, J. M., & Rimer, B. K. (2009). Health literacy and cancer risk perception: Implications for genomic risk communication. Medical Decision Making, 29(2), 157–166. doi:10.1177/0272989X08327111
  • Clayton, J., Butow, P., Tattersall, M., Chye, R., Noel, M., Davis, J. M., & Glare, P. (2003). Asking questions can help: Development and preliminary evaluation of a question prompt list for palliative care patients. British Journal of Cancer, 89(11), 2069–2077. doi:10.1038/sj.bjc.6601380
  • Clinical Care Options. (2018, May 14). Clinical Care Options website. Retrieved from https://www.clinicaloptions.com/
  • Cortez, S., Milbrandt, M., Kaphingst, K., James, A., & Colditz, G. (2015). The readability of online breast cancer risk assessment tools. Breast Cancer Research and Treatment, 154(1), 191–199. doi:10.1007/s10549-015-3601-2
  • Davis, K., Haisfield, L., Dorfman, C., Krist, A., & Taylor, K. L. (2011). Physicians’ attitudes about shared decision making for prostate cancer screening. Family Medicine, 43(4), 260–266.
  • Dinan, M. A., Mi, X., Reed, S. D., Hirsch, B. R., Lyman, G. H., & Curtis, L. H. (2015). Initial trends in the use of the 21-gene recurrence score assay for patients with breast cancer in the Medicare population, 2005-2009. JAMA Oncology, 1(2), 158–166. doi:10.1001/jamaoncol.2015.43
  • Epstein, R. M., & Street, R. L., Jr. (2007). Patient-Centered Communication in Cancer Care: Promoting Healing and Reducing Suffering. Bethesda, MD: National Cancer Institute, NIH Publication No. 07-6225. Retrieved from https://healthcaredelivery.cancer.gov/pcc/pcc_monograph.pdf?file=/pcc/communication/pcc_monograph.pdf
  • Evans, C. N., Brewer, N. T., Vadaparampil, S. T., Boisvert, M., Ottaviano, Y., Lee, M. C., … O’Neill, S. C. (2016). Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy. Breast Cancer Research and Treatment, 156(3), 549–555. doi:10.1007/s10549-016-3780-5
  • Fagerlind, H., Kettis, A., Glimelius, B., & Ring, L. (2013). Barriers against psychosocial communication: Oncologists’ perceptions. Journal of Clinical Oncology, 31(30), 3815–3822. doi:10.1200/JCO.2012.45.1609
  • Freedman, A. N., Wideroff, L., Olson, L., Davis, W., Klabunde, C., Srinath, K. P., … Ballard-Barbash, R. (2003). US physicians’ attitudes toward genetic testing for cancer susceptibility. American Journal of Medical Genetics. Part A, 120A(1), 63–71. doi:10.1002/ajmg.a.10192
  • Gray, S. W., Hicks-Courant, K., Cronin, A., Rollins, B. J., & Weeks, J. C. (2014). Physicians’ attitudes about multiplex tumor genomic testing. Journal of Clinical Oncology, 32(13), 1317–1323. doi:10.1200/JCO.2013.52.4298
  • Harris, L. N., Ismaila, N., McShane, L. M., Andre, F., Collyar, D. E., Gonzalez-Angulo, A. M., … Hayes, D. F. (2016). Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology, 34(10), 1134–1150. doi:10.1200/JCO.2015.65.2289
  • Hassett, M. J., Silver, S. M., Hughes, M. E., Blayney, D. W., Edge, S. B., Herman, J. G., … Weeks, J. C. (2012). Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer. Journal of Clinical Oncology, 30(18), 2218–2226. doi:10.1200/JCO.2011.38.5740
  • Johnson, L. M., Valdez, J. M., Quinn, E. A., Sykes, A. D., McGee, R. B., Nuccio, R., … Mandrell, B. N. (2017). Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics. Cancer, 123(12), 2352–2359. doi:10.1002/cncr.30581
  • Kimmick, G., Fleming, S. T., Sabatino, S. A., Wu, X. C., Hwang, W., Wilson, J. F., … Anderson, R. T. (2014). Comorbidity burden and guideline-concordant care for breast cancer. Journal of the American Geriatrics Society, 62(3), 482–488. doi:10.1111/jgs.12687
  • Lea, D. H., Kaphingst, K. A., Bowen, D., Lipkus, I., & Hadley, D. W. (2011). Communicating genetic and genomic information: Health literacy and numeracy considerations. Public Health Genomics, 14(4–5), 279–289. doi:10.1159/000294191
  • Lipkus, I. M., Peters, E., Kimmick, G., Liotcheva, V., & Marcom, P. (2010). Breast cancer patients’ treatment expectations after exposure to the decision aid program adjuvant online: The influence of numeracy. Medical Decision Making, 30(4), 464–473. doi:10.1177/0272989X09360371
  • Marteau, T. M., Dormandy, E., & Michie, S. (2001). A measure of informed choice. Health Expectations, 4(2), 99–108.
  • McCormack, L. A., Treiman, K., Rupert, D., Williams-Piehota, P., Nadler, E., Arora, N. K., … Street, R. L., Jr. (2011). Measuring patient-centered communication in cancer care: A literature review and the development of a systematic approach. Social Science & Medicine, 72(7), 1085–1095. doi:10.1016/j.socscimed.2011.01.020
  • National Comprehensive Cancer Network. (2018, May 14). NCCN clinical practice guidelines in oncology. Breast Cancer. Version 1.2018. Retrieved from https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
  • National Health Service (NHS), U. (2017). Predict. Retrieved May 14, 2018, from http://www.predict.nhs.uk/index.html
  • Noone, A. M., Cronin, K. A., Altekruse, S. F., Howlader, N., Lewis, D. R., Petkov, V. I., & Penberthy, L. (2017). Cancer incidence and survival trends by subtype using data from the Surveillance Epidemiology and End Results Program, 1992-2013. Cancer Epidemiology, Biomarkers & Prevention, 26(4), 632–641. doi:10.1158/1055-9965.EPI-16-0520
  • O’Neill, S. C., Isaacs, C., Chao, C., Tsai, H. T., Liu, C., Ekezue, B. F., … Potosky, A. L. (2015). Adoption of gene expression profiling for breast cancer in US oncology practice for women younger than 65 years. Journal of the National Comprehensive Cancer Network, 13(10), 1216–1224. doi:10.6004/jnccn.2015.0150
  • O’Neill, S. C., Luta, G., Peshkin, B. N., Abraham, A., Walker, L. R., & Tercyak, K. P. (2009). Adolescent medical providers’ willingness to recommend genetic susceptibility testing for nicotine addiction and lung cancer risk to adolescents. Journal of Pediatric Psychology, 34(6), 617–626. doi:10.1093/jpepsy/jsn086
  • O’Neill, S. C., Peshkin, B. N., Luta, G., Abraham, A., Walker, L. R., & Tercyak, K. P. (2010). Primary care providers’ willingness to recommend BRCA1/2 testing to adolescents. Familial Cancer, 9(1), 43–50. doi:10.1007/s10689-009-9243-y
  • Peele, P. B., Siminoff, L. A., Xu, Y., & Ravdin, P. M. (2005). Decreased use of adjuvant breast cancer therapy in a randomized controlled trial of a decision aid with individualized risk information. Medical Decision Making, 25(3), 301–307. doi:10.1177/0272989X05276851
  • Pinheiro, A. P., Pocock, R. H., Dixon, M. D., Shaib, W. L., Ramalingam, S. S., & Pentz, R. D. (2017). Using metaphors to explain molecular testing to cancer patients. Oncologist, 22(4), 445–449. doi:10.1634/theoncologist.2016-0270
  • Potosky, A. L., O’Neill, S. C., Isaacs, C., Tsai, H. T., Chao, C., Liu, C., … Schwartz, M. D. (2015). Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years. Cancer, 121(22), 4062–4070. doi:10.1002/cncr.29621
  • Reyna, V. F., Nelson, W. L., Han, P. K., & Dieckmann, N. F. (2009). How numeracy influences risk comprehension and medical decision making. Psychological Bulletin, 135(6), 943–973. doi:10.1037/a0017327
  • Richman, A. R., Tzeng, J. P., Carey, L. A., Retel, V. P., & Brewer, N. T. (2011). Knowledge of genomic testing among early-stage breast cancer patients. Psycho-Oncology, 20(1), 28–35. doi:10.1002/pon.1699
  • Shachar, S. S., & Muss, H. B. (2016). Internet tools to enhance breast cancer care. NPJ Breast Cancer, 2, 16011. doi:10.1038/npjbcancer.2016.11
  • Siminoff, L. A., Gordon, N. H., Silverman, P., Budd, T., & Ravdin, P. M. (2006). A decision aid to assist in adjuvant therapy choices for breast cancer. Psycho-Oncology, 15(11), 1001–1013. doi:10.1002/pon.1040
  • Spellman, E., Sulayman, N., Eggly, S., Peshkin, B. N., Isaacs, C., Schwartz, M. D., & O’Neill, S. C. (2013). Conveying genomic recurrence risk estimates to patients with early-stage breast cancer: Oncologist perspectives. Psycho-Oncology, 22(9), 2110–2116. doi:10.1002/pon.3264
  • Street, R. L., Jr. (2013). How clinician-patient communication contributes to health improvement: Modeling pathways from talk to outcome. Patient Education and Counseling, 92(3), 286–291. doi:10.1016/j.pec.2013.05.004
  • Street, R. L., Jr., Makoul, G., Arora, N. K., & Epstein, R. M. (2009). How does communication heal? Pathways linking clinician-patient communication to health outcomes. Patient Education and Counseling, 74(3), 295–301. doi:10.1016/j.pec.2008.11.015
  • Sulayman, N., Spellman, E., Graves, K. D., Peshkin, B. N., Isaacs, C., Schwartz, M. D., & O’Neill, S. C. (2012). Psychosocial and quality of life in women receiving the 21-gene recurrence score assay: The impact of decision style in women with intermediate RS. Journal of Cancer Epidemology, 2012, 728290. doi:10.1155/2012/728290
  • Visser, M., Deliens, L., & Houttekier, D. (2014). Physician-related barriers to communication and patient- and family-centred decision-making towards the end of life in intensive care: A systematic review. Critical Care, 18(6), 604. doi:10.1186/s13054-014-0604-z
  • Wu, A. H., Kurian, A. W., Kwan, M. L., John, E. M., Lu, Y., Keegan, T. H., … Vigen, C. (2015). Diabetes and other comorbidities in breast cancer survival by race/ethnicity: The California Breast Cancer Survivorship Consortium (CBCSC). Cancer Epidemiology, Biomarkers & Prevention, 24(2), 361–368. doi:10.1158/1055-9965.EPI-14-1140
  • Yennurajalingam, S., Rodrigues, L. F., Shamieh, O. M., Tricou, C., Filbet, M., Naing, K., … Bruera, E. (2018). Decisional control preferences among patients with advanced cancer: An international multicenter cross-sectional survey. Palliative Medicine, 32(4), 870–880. doi:10.1177/0269216317747442

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.